BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6813092)

  • 1. Treatment of pseudomonal endocarditis with high-dose aminoglycosides.
    Rybak MJ; Boike SC; Bush PW
    Drug Intell Clin Pharm; 1982 Sep; 16(9):700-2. PubMed ID: 6813092
    [No Abstract]   [Full Text] [Related]  

  • 2. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.
    Reyes MP; Lerner AM
    Rev Infect Dis; 1983; 5(2):314-21. PubMed ID: 6405476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
    Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin.
    Gavin PJ; Suseno MT; Cook FV; Peterson LR; Thomson RB
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):427-30. PubMed ID: 14522517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy with combinations of aminoglycosides and other antibiotics].
    Stille W
    Adv Clin Pharmacol; 1978; 15():127-40. PubMed ID: 676871
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-nosocomial healthcare-associated left-sided Pseudomonas aeruginosa endocarditis: a case report and literature review.
    Hagiya H; Tanaka T; Takimoto K; Yoshida H; Yamamoto N; Akeda Y; Tomono K
    BMC Infect Dis; 2016 Aug; 16(1):431. PubMed ID: 27543116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa endocarditis. Report of a case, with review of the literature.
    Carruthers MM; Kanokvechayant R
    Am J Med; 1973 Dec; 55(6):811-8. PubMed ID: 4201852
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas bacterial endocarditis. A case report.
    Gitau W; Karo E
    East Afr Med J; 1973 May; 50(5):266-71. PubMed ID: 4355898
    [No Abstract]   [Full Text] [Related]  

  • 9. Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis.
    Hoff GE; Schiotz PO; Paulsen J
    Scand J Infect Dis; 1974; 6(4):333-7. PubMed ID: 4217466
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.
    Reyes MP; Smith F; Lerner AM
    J Infect; 1984 Mar; 8(2):110-7. PubMed ID: 6725964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Pseudomonas aeruginosa infective endocarditis via haemodialysis outpatient parenteral antimicrobial therapy: case report.
    Maxwell-Scott H; Thangarajah R; Arnold A; Wade P; Klein JL
    J Antimicrob Chemother; 2019 Jun; 74(6):1757-1759. PubMed ID: 30830217
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
    Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
    Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES).
    Al-Aloul M; Miller H; Stockton P; Ledson MJ; Walshaw MJ
    J Cyst Fibros; 2005 Sep; 4(3):197-201. PubMed ID: 15967735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy.
    Reyes MP; Brown WJ; Lerner AM
    Medicine (Baltimore); 1978 Jan; 57(1):57-67. PubMed ID: 618441
    [No Abstract]   [Full Text] [Related]  

  • 16. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas endocarditis.
    Reyes MP; Lerner AM
    JAMA; 1979 Apr; 241(15):1576. PubMed ID: 107332
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel approaches for the use of aminoglycosides: the value of experimental models.
    Kapusnik JE; Sande MA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():7-10. PubMed ID: 3710965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Baddour LM; Steckelberg JM; Wilson WR
    J Antimicrob Chemother; 2006 Jun; 57(6):1255; author reply 1255-6. PubMed ID: 16549509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.